SEN-JAM PHARMACEUTICAL INC. — Form D/A
SEN-JAM PHARMACEUTICAL INC. of HUNTINGTON, NY, a company, filed a Form D amendment with the SEC on 2020-06-02. The offering totals $3.2M, of which $185K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-06-02
- Form: D/A
- Accession: 0001567619-20-011530
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $3.2M
- Amount sold: $185K
- Remaining: $3.1M
- Investors: 5
- Date of first sale: 2020-01-28
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-359878
Issuer
- Name: SEN-JAM PHARMACEUTICAL INC.
- CIK: 0001802249
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 223 WALL STREET, #130, HUNTINGTON, NY, 11743
- Phone: 201-400-8083
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| James Iversen | Promoter | Huntington, NY |
| Jacqueline Iversen | Executive Officer | Huntington, NY |
| James Iversen | Director | Huntington, NY |
| James Iversen | Executive Officer | Huntington, NY |
| James Wall Street Iversen | Executive Officer | Huntington, NY |
Other filings by this issuer (3)
More